First therapy targeting Parkinson's proteins enters clinical trials

被引:5
|
作者
Dolgin, Elie
机构
关键词
D O I
10.1038/nm0712-992b
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:992 / 993
页数:2
相关论文
共 50 条
  • [31] Therapeutic antibodies' CytoTAb enters clinical trials
    不详
    DRUG NEWS & PERSPECTIVES, 1997, 10 (08) : 487 - 487
  • [32] New drug enters PDT clinical trials
    Hitt, E
    LANCET ONCOLOGY, 2003, 4 (03): : 136 - 136
  • [33] Targeting Nicotinic Receptors for Parkinson's Disease Therapy
    Quik, Maryka
    Bordia, Tanuja
    Huang, Luping
    Perez, Xiomara
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2011, 10 (06) : 651 - 658
  • [34] Targeting cardiolipin metabolism for Parkinson's disease therapy
    Liu, Junli
    Dalamaga, Maria
    METABOLISM OPEN, 2024, 24
  • [35] Targeting epigenetic modifications in Parkinson's disease therapy
    Zhang, Dan
    Zhang, Jifa
    Wang, Yuxi
    Wang, Guan
    Tang, Pan
    Liu, Yun
    Zhang, Yiwen
    Ouyang, Liang
    MEDICINAL RESEARCH REVIEWS, 2023, 43 (05) : 1748 - 1777
  • [36] Ongoing clinical trials on Parkinson's disease in Europe
    Eggert, K.
    ACTA NEUROLOGICA SCANDINAVICA, 2008, 117 (01): : 65 - 65
  • [37] Placebo effects in Parkinson's disease clinical trials
    Goetz, CG
    Leurgans, S
    Raman, R
    Stebbins, GT
    NEUROLOGY, 1998, 50 (04) : A71 - A71
  • [38] Neuroprotection in Parkinson's disease: Clinical trials - Discussion
    Hunot
    Stocchi
    Keiburtz
    Tatton
    Olanow
    Brooks
    Rascol
    Beal
    Marek
    Schapiro
    ANNALS OF NEUROLOGY, 2003, 53 : S97 - S99
  • [39] Issues in neuroprotection clinical trials in Parkinson's disease
    Kieburtz, K
    NEUROLOGY, 2006, 66 (10) : S50 - S57
  • [40] Minority enrollment in Parkinson's disease clinical trials
    Schneider, Myra G.
    Swearingen, Christopher J.
    Shulman, Lisa M.
    Ye, Jian
    Baumgarten, Mona
    Tilley, Barbara C.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 (04) : 258 - 262